UNITED STATES
                          SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549

                                      FORM 10-Q


          [X] Quarterly Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
          For the quarter ended June 30, 1994                           

                                          or

          [ ] Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
          For the transition period from          to

          Commission File Number:                 1-7234
           
                       NATIONAL PATENT DEVELOPMENT CORPORATION
                                                                         
                (Exact Name of Registrant as Specified in its Charter)

          Delaware                                     13-1926739
          (State or other jurisdiction of         (I.R.S. Employer
          incorporation or organization)          Identification No.)

          9 West 57th Street, New York, NY                  10019
          (Address of principal executive offices)          (Zip code)

          (212) 826-8500
          (Registrant's telephone number, including area code)

          Indicate by check mark whether the registrant (1) has filed all
          reports required to be filed by Section 13 or 15(d) of the
          Securities Exchange act of 1934 during the preceding 12 months
          (or for such shorter period) that the registrant was required to
          file such reports and (2) has been subject to such filing
          requirements for the past 90 days.
            
                    Yes    X                      No

          Number of shares outstanding of each of issuer's classes of
          common stock as of August 9, 1994:


                            Common Stock        23,854,255 shares
                            Class B Capital        250,000 shares


















               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                                  TABLE OF CONTENTS


                                                                  Page No.

          Part I.  Financial Information


                   Consolidated Condensed Balance Sheets -
                    June 30, 1994 and December 31, 1993                1
                                                      
                   Consolidated Condensed Statements of Operations -  
                    Three Months and Six Months Ended June 30,
                    1994 and 1993                                      3
           
                   Consolidated Condensed Statements of Cash Flows - 
                    Six Months Ended June 30, 1994 and 1993            4

                   Notes to Consolidated Condensed Financial
                    Statements                                         6

                   Management's Discussion and Analysis of Financial
                    Condition and Results of Operations                9

                   Qualification Relating to Financial Information     14

          Part II.  Other Information                                  15

                    Signatures                                         16





















                            PART I.  FINANCIAL INFORMATION

               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                        CONSOLIDATED CONDENSED BALANCE SHEETS

                                    (in thousands)

                                                  June 30,    December 31,
                                                    1994          1993    
                           ASSETS               (unaudited)         *     

          Current assets

          Cash and cash equivalents               $ 10,475       $ 10,976 
          Accounts and other receivables            45,312         36,285 
          Inventories                               24,735         22,605 
          Costs and estimated earnings in excess
           of billings on uncompleted contracts     16,919         13,081 
          Prepaid expenses and other current
           assets                                    3,904          4,160 

          Total current assets                     101,345         87,107 

          Investments and advances                  26,988         28,303 

          Property, plant and equipment, at cost    35,607         33,873 
          Less accumulated depreciation            (21,388)       (20,035)
                                                    14,219         13,838 

          Intangible assets, net of amortization    29,105         30,104 

          Investment in financed assets              1,521          2,797 

          Other assets                               3,523          3,908 
                                                  $176,701       $166,057 

            
          * The Consolidated Condensed Balance Sheet as of December 31,
          1993 has been summarized from the Company's audited Consolidated
          Balance Sheet as of that date.
            
          See accompanying notes to the consolidated condensed financial
          statements.









                                          1



               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                 CONSOLIDATED CONDENSED BALANCE SHEETS (Continued)  

                                    (in thousands)


                                                 June 30,     December 31,
                                                    1994          1993    
          LIABILITIES AND STOCKHOLDERS' EQUITY  (unaudited)         *     

          Current liabilities

          Current maturities of long-term debt
           and notes payable                      $ 20,592       $  6,750 
          Short-term borrowings                     29,475         21,390 
          Accounts payable and accrued expenses     24,462         20,256 
          Billings in excess of costs and
           estimated earnings on uncompleted
            contracts                                8,195          5,487 

          Total current liabilities                 82,724         53,883 

          Long-term debt less current maturities    22,419         36,638 

          Notes payable for financed assets            199            579 

          Minority interests and other               3,621          3,277 

          Common stock issued subject to
           repurchase obligation                     1,510          4,242 

          Stockholders' equity

          Common stock                                 198            190 
          Class B capital stock                          2              2 
          Capital in excess of par value           109,859        106,274 
          Deficit                                  (43,831)       (39,028)
          Total stockholders' equity                66,228         67,438 
                                                  $176,701       $166,057 
           

          * The Consolidated Condensed Balance Sheet as of December 31,
          1993 has been summarized from the Company's audited Consolidated
          Balance sheet as of that date.


          See accompanying notes to the consolidated condensed financial
          statements.




                                          2


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                   CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                                     (Unaudited)

                        (in thousands, except per share data)

                                         Three months     Six months     
                                        ended June 30,   ended June 30,        

                                         1994     1993    1994     1993   
           Revenues
            Sales                     $ 52,191 $ 55,114 $ 97,423 $100,078 
            Investment and other
              income, net               (1,258)   1,560   (2,010)   3,468 
                                        50,933   56,674   95,413  103,546 

          Costs and expenses
            Cost of goods sold          42,692   46,154   79,677   84,925 
            Selling, general &
             administrative              9,169    9,898   17,367   18,195 
            Research & development         105    1,126      225    2,316 
            Interest                     1,451    2,487    2,954    4,960 
                                        53,417   59,665  100,223  110,396 
          Minority interests               (36)   1,083     (104)   2,003 
          Gain on issuance of stock
           by a subsidiary                 229               229 
          Loss before income taxes and
            extraordinary item          (2,291)  (1,908)  (4,685)  (4,847)
          Income tax expense               (52)     (80)    (118)     (45)
          Loss before extraordinary
           item                         (2,343)  (1,988)  (4,803)  (4,892)

          Extraordinary item 
            Early extinguishment
             of debt, net of income tax
             in 1993                                101               227 

          Net loss                     $(2,343) $(1,887) $(4,803) $(4,665)

          Loss per share
           Loss before extraordinary
            item                       $  (.12) $  (.13) $  (.25) $  (.31)
           Extraordinary item                       .01               .02 
          Net loss per share           $  (.12) $  (.12) $  (.25) $  (.29)
          Dividends per share             none     none    none     none  


          See accompanying notes to the consolidated condensed financial
          statements.



                                          3


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                   CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

                                     (Unaudited)

                                    (in thousands)
                                                           Six months
                                                         ended June 30,
                                                         1994      1993   
          Cash flows provided by (used for) operations:

          Net loss                                      $(4,803)  $(4,665)
          Adjustments to reconcile net income
            to net cash used for operating activities:
            Depreciation and amortization                 2,152     3,049 
            Gains from early extinguishment of debt                  (357)
            Changes in other operating items             (7,634)   (3,805)
            Total adjustments                            (5,482)   (1,113)
            Net cash used for operations                (10,285)   (5,778)

          Cash flows provided by (used for) investing activities:

          Marketable securities                                       651 
          Additions to property, plant & equipment       (1,734)   (1,433)
          Additions to intangible assets, net              (239)      (10)
          Reduction of investments and other
           assets, net                                    2,332     1,053 
          Net cash provided by investing activities         359       261 

          Cash flows provided by (used for) financing activities:

          Net proceeds from (repayments of)
           short-term borrowings                          8,085    (8,660)
          Decrease in restricted cash                               1,200 
          Proceeds from issuance of long-term debt        3,163    17,283 
          Reduction of long-term debt                    (2,011)   (7,765)
          Exercise of common stock options and warrants     100        91 
          Proceeds from issuance of common stock             88 
          Proceeds from stock purchase agreement
           entered into by a subsidiary                             1,408 
          Net cash provided by financing activities       9,425     3,557 

          Net decrease in cash and cash equivalents        (501)   (1,960)
          Cash and cash equivalents at the beginning
           of the periods                                10,976    17,921 
          Cash and cash equivalents at the end
           of the periods                               $10,475   $15,961 





                                          4


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

             CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Continued)

                                     (Unaudited)

                                    (in thousands)


                                                         Six months
                                                        ended June 30,
                                                     1994          1993 

          Supplemental disclosures of
           cash flow information:

          Cash paid during the periods for:
           Interest                               $ 2,135       $ 3,563 
           Income taxes                           $   261       $   352 




          See accompanying notes to the consolidated condensed financial
          statements.




























                                          5


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                 NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                     (Unaudited)

          1.   Inventories

               Inventories are valued at the lower of cost or market,
          principally using the first-in, first-out (FIFO) method. 
          Inventories consisting of material, labor, and overhead are
          classified as follows (in thousands):
                                                June 30,      December
                                                  1994          1993 
          Raw materials                         $ 2,686       $ 2,836 
          Work in process                           423           675 
          Finished goods                         18,926        16,394 
          Land held for resale                    2,700         2,700 
                                                $24,735       $22,605 

          2.   Long-term debt

               Long-term debt consists of the following (in thousands):

                                                June 30,      December
                                                  1994          1993  
          8% Swiss bonds                        $ 5,308       $ 4,572 
          Swiss convertible bonds                16,594        15,300 
          New 5% convertible bonds                2,080         2,300 
          12% Subordinated debentures             6,790         6,829 
          Other                                  10,755        11,857 
                                                 41,527        40,858 
          Less current maturities                19,108         4,220 
                                                $22,419       $36,638 

               On June 10, 1993, the Company commenced an Exchange Offer
          for up to 60% of its Swiss denominated 8% Bonds due March 1,
          1995, 6% Convertible Bonds due March 7, 1995, 5 % Convertible
          Bonds due May 9, 1995, 5 % Convertible Bonds due March 18, 1996
          and 7% Dual Currency Bonds due March 18, 1996, ("the Bonds").
          The Company offered for exchange its Common Stock with a value of
          $1,000 for each $1,000 principal amount of the Bonds.











                                          6


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

           NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                     (Unaudited)


          2.   Long-term debt (Continued)

               In addition, the Company offered for exchange its Common
          Stock with a value of SFr. 1,000 for each SFr. 1,000 principal
          amount of the Bonds.  Accrued interest the Old Bonds accepted for
          exchange by the Company will be paid in Common Stock of the
          Company.  The purpose of the Exchange Offer is to reduce the
          Company's long-term indebtedness and related interest expense.

               In July, as a result of the Exchange Offer, the Company
          received an aggregate of SFr. 2,569,000 principal amount of its
          Swiss denominated bonds and $1,377,000 of its 7% Dual Currency
          Convertible Bonds.  In addition, the Company completed two
          private transactions for SFr. 6,515,000 principal amount of its
          Swiss denominated bonds and $45,000 of its 7% Dual Currency
          Convertible Bonds.

               As a result of the above transactions, the Company will
          issue approximately 3,222,000 shares of its common stock, reduce
          its long-term debt by approximately $8,100,000, increase
          shareholders' equity by approximately $9,100,000 and will reduce
          its interest expense by approximately $750,000 on an annual
          basis.

          3.   GPS Technologies, Inc.

               On April 7, 1994, General Physics Corporation (GP) entered
          into an agreement with GPS Technologies, Inc. (GPS) and the
          Company to acquire substantially all of the operating assets of
          GPS and certain of its subsidiaries.  The Company currently owns
          approximately 92% of the outstanding common stock of GPS and
          approximately 28% of the outstanding common stock of GP.  GP
          agreed to pay GPS a purchase price with a then present value of
          approximately $36 million.  The purchase price will be payable to
          GPS as follows: $10 million in cash; 3.5 million shares of GP
          common stock valued at approximately $13,500,000 (based upon the
          price per share of GP common stock prior to the announcement of
          the transaction which was $3.875); warrants to acquire 1,000,000
          shares of GP common stock at $6.00 per share valued at
          approximately $1,300,000; warrants to acquire up to 475,644
          additional shares of GP common stock at $7 per share valued at
          approximately $500,000; and 6% Senior Subordinated Debentures due
          2004 (the "Debentures"), in the aggregate principal amount of
          $15,000,000, valued at approximately $10,700,000.  The values
          assigned to each component of consideration were based upon (i)

                                          7

          discussions with the independent investment banker to the
          Independent Committee of GP and the investment banker to GPS and
          (ii) negotiations between the Independent Committee of GP and the
          Board of Directors of GPS.  Portions of the cash and stock
          consideration of the purchase price will be (a) used to repay
          outstanding bank debt, which as of June 30, 1994 was $6,800,000
          and long-term debt of GPS, which as of June 30, 1994 was
          $9,400,000 to be repaid to the Company and (b) held in escrow.  

          The transaction is contingent upon the occurrence of certain
          events, including, without limitation, the approval of the
          transaction by the stockholders of GP and GPS.  The transaction
          is anticipated to close as soon as practicable in the second half
          of 1994, if all necessary approvals are obtained and conditions
          satisfied.  The Company anticipates that, if the aforementioned
          transaction is consummated, it will own approximately 52% of the
          outstanding common stock of GP, and if the Company were to
          exercise all of its warrants, it would own approximately 58% of
          the outstanding common stock of GP.  The Company will account for
          this transaction as a purchase by the Company of GP.

































                                          8



               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

             MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                              AND RESULTS OF OPERATIONS

                                RESULTS OF OPERATIONS

            The Company incurred a loss before income taxes and
          extraordinary item of $2,291,000 and $4,685,000 for the quarter
          and six months ended June 30, 1994, as compared with a loss of
          $1,908,000 and $4,847,000 for the corresponding periods of 1993. 
          The increase in the Company's loss before extraordinary item is
          due to several factors.  Included in investment and other income,
          net for the quarter and six months ended June 30, 1994, is
          $1,115,000 and $2,012,000, respectively, of foreign currency
          transaction losses, compared to gains of $711,000 and $1,381,000
          for the corresponding periods of 1993.  For the quarter and six
          months ended June 30, 1994, the foreign currency transaction
          losses were partially offset by reduced interest expense at the
          corporate level, as a result of reduced long-term debt, as well
          as increased operating profits achieved by the Physical Science
          and Optical Plastics Group.  Foreign currency valuation
          fluctuations may adversely affect the results of operations and
          financial condition of the Company.  At June 30, 1994, the
          Company had not hedged its Swiss franc obligations.  If the value
          of the Swiss franc to the U.S. dollar increases, the Company will
          recognize transaction losses on its Swiss franc obligations.  On
          June 30, 1994, the value of the Swiss franc to the U.S. dollar
          was approximately 1.3335 to 1.  There can be no assurance that
          the Company will be able to swap or hedge obligations denominated
          in foreign currencies at prices acceptable to the Company or at
          all.  The Company will continue to review this policy on a
          continuing basis.  In July 1994, as a result of the transactions
          discussed in Note 2 to the Notes to the consolidated condensed
          financial statements, the Company had approximately SFr.
          16,500,000 of Swiss denominated debt outstanding, of which
          approximately SFr. 15,000,000 represents principal amount
          outstanding and approximately SFr. 1,500,000 represents interest
          accrued thereon.













                                          9


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

             MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                        AND RESULTS OF OPERATIONS (Continued)


          Sales

            For the quarter ended June 30, 1994, consolidated sales
          decreased by $2,923,000 to $52,191,000 from the $55,114,000
          recorded in the corresponding quarter of 1993.  For the six
          months ended June 30, 1994, consolidated sales decreased by
          $2,655,000 to $97,423,000 from $100,078,000 recorded for the six
          months ended June 30, 1993.  The decreased sales during the
          periods were the result of reduced sales in the Physical Science
          Group, partially offset by increased sales within the Optical
          Plastics Group.  In addition, the Electronics Group also had
          reduced sales.  The reduced sales within the Physical Science
          Group were the result of the end of a long-term staff
          augmentation contract at GTS Duratek, Inc. (Duratek), partially
          offset by increased Environmental Services revenues, as well as
          the sale by GPS Technologies, Inc. (GPS) of its interest in
          General Physics International Engineering and Simulation, Inc.
          (GPI) to a new joint venture in which GPS has a minority
          position, in 1994.  For the quarter ended June 30, 1993, GPI had
          sales of $3,408,000.

          Gross margin

            Consolidated gross margin of $9,499,000, or 18%, for the
          quarter ended June 30, 1994, increased by $539,000 when compared
          to the consolidated gross margin of $8,960,000, or 16%, for the
          quarter ended June 30, 1993.  For the six months ended June 30,
          1994, consolidated gross margin of $17,746,000 or 18% of
          consolidated sales increased by $2,593,000 when compared to
          $15,153,000 or 15% of consolidated sales earned in the six months
          ended June 30, 1993.  The increased gross margin for the quarter
          and six months ended June 30, 1994, was primarily the result of
          increased sales and gross margin percentage achieved by the
          Optical Plastics Group, as well increased gross margin achieved
          by the Physical Science Group due to the higher gross margin
          generated by Duratek's Environmental Services business and a more
          profitable mix of services generated by GPS.









                                          10


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

             MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                        AND RESULTS OF OPERATIONS (Continued)

          Selling, general and administrative expenses

            For the quarter and six months ended June 30, 1994, selling,
          general and administrative expenses (SG&A) of $9,169,000 and
          $17,367,000 were $729,000 and $828,000 lower than the $9,898,000
          and $18,195,000 of SG&A expenses incurred during the quarter and
          six months ended June 30, 1993.  The decrease in SG&A for the
          quarter and six months ended June 30, 1994, was the result of
          Interferon Sciences, Inc. (ISI) being accounted for on the equity
          method since the third quarter of 1993, partially offset by
          increased costs incurred by the Distribution Group.

          Research and development

            Research and development costs of $105,000 and $225,000 for the
          quarter and six months ended June 30, 1994, were reduced
          significantly when compared to costs of $1,126,000 and $2,316,000
          for the quarter and six months ended June 30, 1993, as a result
          of ISI being accounted for on the equity basis since June 1993.

          Interest expense

            For the quarter and six months ended June 30, 1994, interest
          expense was $1,451,000 and $2,954,000, compared to $2,487,000 and
          $4,960,000 for the second quarter and six months ended June 30,
          1993.  The decreased interest expense for the periods was the
          result of reduced long-term debt.




















                                          11



               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

             MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                        AND RESULTS OF OPERATIONS (Continued)


          Investment and other income, net

            Investment and other income, net of $(1,258,000) and
          $(2,010,000) for the quarter and six months ended June 30, 1994,
          decreased by $2,818,000 and $5,478,000, respectively, as compared
          to $1,560,000 and $3,468,000 for the corresponding periods of
          1993.  The change was principally due to two factors; $1,115,000
          and $2,012,000 of foreign currency transaction losses recognized
          during the quarter and six months ended June 30, 1994, compared
          to gains of $711,000 and $1,381,000 for the corresponding periods
          of 1993 and a loss of $1,050,000 and $1,820,000 realized in the
          quarter and six months ended June 30, 1994, respectively, on the
          share of losses of 20% to 50% owned subsidiaries, compared to
          $175,000 and $351,000 earned in the quarter and six months ended
          June 30, 1993, respectively, primarily as a result of the results
          of Interferon Sciences, Inc. (ISI) being accounted for on the
          equity basis since the third quarter of 1993.  For the quarter
          and six months ended June 30, 1994, the Company's share of ISI's
          loss was $900,000 and $1,620,000, respectively.  In the quarter
          and six months ended June 30, 1993, ISI was included in the
          consolidated results of the Company and its loss was therefore
          not reflected in Investment and other income, net.
























                                          12


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                           LIQUIDITY AND CAPITAL RESOURCES



            The Company believes that it has sufficient cash, cash
          equivalents and borrowing availability under existing and
          potential lines of credit to satisfy its cash requirements until
          the first scheduled maturity of its Swiss Franc denominated
          indebtedness on March 1, 1995.  However, in order for the Company
          to meet its long-term cash needs, which include the repayment,
          (after giving effect to the July 1994 transactions described in
          Note 2 to the Consolidated Condensed Financial Statements) of
          approximately $9,700,000 of Swiss Franc denominated indebtedness
          scheduled to mature in 1995 and approximately $4,200,000 of Swiss
          Franc denominated indebtedness which is scheduled to mature in
          1996, the Company must obtain additional funds from among various
          sources.  The Company has historically reduced its long-term debt
          through the issuance of equity securities in exchange for long-
          term debt.    In addition to its ability to issue equity
          securities, the Company believes that it has sufficient
          marketable long-term investments, as well as the ability to
          obtain additional funds from its operating subsidiaries and the
          potential to enter into new credit arrangements.  The Company
          reasonably believes that it will be able to continue to
          accomplish some or all of the above transactions  in order to
          fund the scheduled repayment of the Company's long-term Swiss
          debt in 1995. 

            At June 30, 1994, the Company had cash and, cash equivalents 
          totaling $10,475,000.  GPS and Duratek had cash and, cash
          equivalents of $116,000 at June 30, 1994.  The minority interests
          of these two companies are owned by the general public, and
          therefore the assets of these subsidiaries have been dedicated to
          the operations of these companies and may not be readily
          available for the general corporate purpose of the parent.
















                                          13


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                   QUALIFICATION RELATING TO FINANCIAL INFORMATION

                                    June 30, 1994



            The financial information included herein is unaudited.  In
          addition, the financial information does not include all
          disclosures required under generally accepted accounting
          principles because certain note information included in the
          Company's Annual Report has been omitted; however, such
          information reflects all adjustments (consisting solely of normal
          recurring adjustments) which are, in the opinion of management,
          necessary to a fair statement of the results for the interim
          periods.  The results for the 1994 interim period are not
          necessarily indicative of results to be expected for the entire
          year.


































                                          14


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                             PART II.  OTHER INFORMATION


          Item 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

                    At the Annual Meeting of shareholders held on June 8,
                    1994, the following matters were voted upon:

                 a. Jerome I. Feldman, Scott N. Greenberg, Paul A. Gould,
                    Roald Hoffmann, Martin M. Pollak and Ogden R. Reid were
                    elected to serve as directors of the Registrant for a
                    one year term.

                 b. The proposal to amend the Company's Restated
                    Certificate of Incorporation to increase the total
                    number of authorized shares of Common Stock which the
                    Company shall have authority to issue from 30,000,000
                    to 40,000,000 shares was adopted with a vote of
                    15,172,217 votes for and 454,941 votes against the
                    adoption of this proposal

                 c. The proposal to reappoint KPMG Peat Marwick as auditors
                    was adopted with a vote of 15,464,198 votes for and
                    85,612 votes against the adoption of this proposal.
                         
          Item 6.   EXHIBITS AND REPORTS ON FORM 8-K

                 a. Exhibits

                    Copy of Notice and Proxy Statement for Annual Meeting
                    of Shareholders held on June 18, 1994, filed with the
                    Securities and Exchange Commission pursuant to Section
                    14 of the Securities Exchange Act of 1934 and
                    incorporated herein by reference.

                 b. Reports on Form 8-K

                    There were no reports filed on Form 8-K for the period
                    ended June 30, 1994.












                                          15


               NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES



                                    June 30, 1994


                                      SIGNATURES


          Pursuant to the requirements of the Securities Exchange Act of
          1934, the registrant has duly caused this report to be signed in
          its behalf by the undersigned thereunto duly authorized.


                                             NATIONAL PATENT DEVELOPMENT
                                             CORPORATION


          DATE: August 12, 1994              BY:  Scott N. Greenberg
                                                  Vice President and
                                                  Chief Financial Officer


          DATE: August 12, 1994              BY:  Jerome I. Feldman
                                                  President and Chief
                                                  Executive Officer


























                                          16